Global Sirolimus Eluting Coronary Stent Market Growth 2023-2029

Global Sirolimus Eluting Coronary Stent Market Growth 2023-2029

Sirolimus eluting coronary stent is made of a coated cobalt-chromium alloy (L605) stent and a rapid-exchange catheter. Sirolimus eluting coronary stent is indicated for use in patients with symptomatic ischemic coronary heart disease due to de novo lesions or restenosed lesions of the coronary arteries. The stent system is also indicated for the treatment of acute or suspected occlusions in patients who respond unsuccessfully to an interventional therapy following balloon dilatation.

LPI (LP Information)' newest research report, the “Sirolimus Eluting Coronary Stent Industry Forecast” looks at past sales and reviews total world Sirolimus Eluting Coronary Stent sales in 2022, providing a comprehensive analysis by region and market sector of projected Sirolimus Eluting Coronary Stent sales for 2023 through 2029. With Sirolimus Eluting Coronary Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sirolimus Eluting Coronary Stent industry.

This Insight Report provides a comprehensive analysis of the global Sirolimus Eluting Coronary Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sirolimus Eluting Coronary Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Sirolimus Eluting Coronary Stent market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sirolimus Eluting Coronary Stent and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sirolimus Eluting Coronary Stent.

The global Sirolimus Eluting Coronary Stent market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Sirolimus Eluting Coronary Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Sirolimus Eluting Coronary Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Sirolimus Eluting Coronary Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Sirolimus Eluting Coronary Stent players cover Cardionovum, Concept Medical, BIOTRONIK, Terumo Europe, Meril Life Sciences, eucatech AG, Eurocor Tech, MedAlliance and Boston Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Sirolimus Eluting Coronary Stent market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Balloon Diameter 2.25-3 mm
Balloon Diameter 3-4 mm
Others

Segmentation by application
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cardionovum
Concept Medical
BIOTRONIK
Terumo Europe
Meril Life Sciences
eucatech AG
Eurocor Tech
MedAlliance
Boston Scientific
Abbott
Vasmed
Alvimedica
B. Braun
Balton

Key Questions Addressed in this Report

What is the 10-year outlook for the global Sirolimus Eluting Coronary Stent market?

What factors are driving Sirolimus Eluting Coronary Stent market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Sirolimus Eluting Coronary Stent market opportunities vary by end market size?

How does Sirolimus Eluting Coronary Stent break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.